Steven Richards is a seasoned biotech executive with over 20 years of extensive experience in drug discovery, currently serving as the President of Richards Discovery Consulting. In this pivotal role, Steven leverages his deep expertise in small molecule drug discovery and development to guide innovative...
Steven Richards is a seasoned biotech executive with over 20 years of extensive experience in drug discovery, currently serving as the President of Richards Discovery Consulting. In this pivotal role, Steven leverages his deep expertise in small molecule drug discovery and development to guide innovative projects that aim to advance novel therapies. His strategic vision encompasses a comprehensive approach to medicinal chemistry, drug discovery strategy, and chemistry diligence, ensuring that each project is meticulously crafted to meet the evolving needs of the biotechnology landscape.
At Richards Discovery Consulting, Steven is at the forefront of several key initiatives, focusing on optimizing hit-to-lead processes and enhancing drug design methodologies. His ability to navigate complex challenges in organic chemistry and biochemistry allows him to lead teams effectively, fostering a collaborative environment that encourages creativity and innovation. Steven’s proficiency in ADME (Absorption, Distribution, Metabolism, and Excretion) studies further enriches his consulting practice, enabling clients to make informed decisions throughout the drug development lifecycle.
As a determined entrepreneur, Steven is always on the lookout for exciting new opportunities that align with his passion for advancing small molecule therapies. His role as a liaison with Contract Research Organizations (CROs) underscores his commitment to building strong partnerships that drive project success. With a keen eye for emerging trends in the life sciences sector, Steven Richards continues to make significant contributions to the field, positioning himself as a thought leader and a catalyst for change in the biotechnology industry.
